Since increased TRIM24 levels observed in gastric cancer patients are functionally related to chemotherapy resistance [61], it is most likely that TRIM24 constitutes an important oncogene in the development of gastrointestinal tumors preventing apoptosis in particular through the inhibition of p53. The gene discussed is TRIM24; the disease is digestive system neoplasm.